Soluble receptor for advanced glycation end-products and progression of airway disease

被引:0
作者
Hiroshi Iwamoto
Jing Gao
Ville Pulkkinen
Tuula Toljamo
Pentti Nieminen
Witold Mazur
机构
[1] University of Helsinki and Helsinki University Central Hospital,Heart and Lung Center, Division of Pulmonary medicine
[2] Hiroshima University,Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences
[3] Lapland Central Hospital,Department of Pulmonary Medicine
[4] University of Oulu,Medical Informatics and Statistics Group
来源
BMC Pulmonary Medicine | / 14卷
关键词
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Chronic Obstructive Pulmonary Disease Group; sRAGE Level; Chronic Obstructive Pulmonary Disease Lung;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 227 条
  • [1] Fritz G(2011)RAGE: a single receptor fits multiple ligands Trends Biochem Sci 36 625-632
  • [2] Buckley ST(2010)The receptor for advanced glycation end products (RAGE) and the lung J Biomed Biotechnol 2010 917108-105
  • [3] Ehrhardt C(2010)Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease Proteomics Clin Appl 4 97-522
  • [4] Ohlmeier S(2011)Reduced soluble receptor for advanced glycation end-products in COPD Eur Respir J 37 516-729
  • [5] Mazur W(2012)Soluble RAGE is deficient in neutrophilic asthma and COPD Eur Respir J 39 721-429
  • [6] Salmenkivi K(2011)Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case–control study Respir Res 12 37-957
  • [7] Myllarniemi M(2014)Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Eur Respir J 43 421-484
  • [8] Bergmann U(2013)Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 188 948-201
  • [9] Kinnula VL(2012)Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity PLoS One 7 e38629-927
  • [10] Smith DJ(2008)HMGB1: endogenous danger signaling Mol Med 14 476-815